Walter M. Stadler to Fibroblast Growth Factors
This is a "connection" page, showing publications Walter M. Stadler has written about Fibroblast Growth Factors.
Connection Strength
0.056
-
A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer. Clin Cancer Res. 2004 May 15; 10(10):3365-70.
Score: 0.056
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.